Figure 1.

A portion of the rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) regimen description for untreated follicular lymphoma. There are currently seven variants of this regimen for this context on HemOnc.org. Study design, efficacy, and toxicity information are shown directly above the regimen. All drug names are active links to the respective drug pages. The original reference is listed at the end of the regimen (references are listed in chronologic order), with links to the original article as well as the PubMed abstract page.